位置:首页 > 蛋白库 > HMDH_PIG
HMDH_PIG
ID   HMDH_PIG                Reviewed;         885 AA.
AC   Q1W675;
DT   31-OCT-2006, integrated into UniProtKB/Swiss-Prot.
DT   02-MAY-2006, sequence version 1.
DT   03-AUG-2022, entry version 105.
DE   RecName: Full=3-hydroxy-3-methylglutaryl-coenzyme A reductase;
DE            Short=HMG-CoA reductase;
DE            EC=1.1.1.34 {ECO:0000250|UniProtKB:P04035};
GN   Name=HMGCR; Synonyms=HMGR;
OS   Sus scrofa (Pig).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Laurasiatheria; Artiodactyla; Suina; Suidae; Sus.
OX   NCBI_TaxID=9823;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND TISSUE SPECIFICITY.
RC   TISSUE=Liver;
RX   PubMed=22240315; DOI=10.1016/j.gene.2011.12.051;
RA   Chen X., Wang X., Li Z., Kong L., Liu G., Fu J., Wang A.;
RT   "Molecular cloning, tissue expression and protein structure prediction of
RT   the porcine 3-hydroxy-3-methylglutaryl-Coenzyme A reductase (HMGR) gene.";
RL   Gene 495:170-177(2012).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA].
RC   TISSUE=Liver;
RA   Wang X.F., Wang A.G., Fu J.L., Li Z.J., Kong L.J., Liu G.F., Fang W.N.,
RA   Lu J.H.;
RT   "Molecular cloning, expression analysis and chromosomal location of the
RT   porcine 3-hydroxy-3-methylglutaryl-coenzyme A reductase (HMGR) gene.";
RL   Submitted (MAY-2006) to the EMBL/GenBank/DDBJ databases.
CC   -!- FUNCTION: Catalyzes the conversion of (3S)-hydroxy-3-methylglutaryl-CoA
CC       (HMG-CoA) to mevalonic acid, the rate-limiting step in the synthesis of
CC       cholesterol and other isoprenoids, thus plays a critical role in
CC       cellular cholesterol homeostasis. {ECO:0000250|UniProtKB:P04035}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(R)-mevalonate + CoA + 2 NADP(+) = (3S)-hydroxy-3-
CC         methylglutaryl-CoA + 2 H(+) + 2 NADPH; Xref=Rhea:RHEA:15989,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:36464, ChEBI:CHEBI:43074,
CC         ChEBI:CHEBI:57287, ChEBI:CHEBI:57783, ChEBI:CHEBI:58349; EC=1.1.1.34;
CC         Evidence={ECO:0000250|UniProtKB:P04035};
CC       PhysiologicalDirection=right-to-left; Xref=Rhea:RHEA:15991;
CC         Evidence={ECO:0000250|UniProtKB:P04035};
CC   -!- ACTIVITY REGULATION: Regulated by a negative feedback mechanism through
CC       sterols and non-sterol metabolites derived from mevalonate (By
CC       similarity). Phosphorylation at Ser-869 down-regulates the catalytic
CC       activity (By similarity). {ECO:0000250|UniProtKB:P00347,
CC       ECO:0000250|UniProtKB:P04035}.
CC   -!- PATHWAY: Metabolic intermediate biosynthesis; (R)-mevalonate
CC       biosynthesis; (R)-mevalonate from acetyl-CoA: step 3/3.
CC   -!- SUBUNIT: Homotetramer. Homodimer. Interacts (via its SSD) with INSIG1;
CC       the interaction, accelerated by sterols, leads to the recruitment of
CC       HMGCR to AMFR/gp78 for its ubiquitination by the sterol-mediated ERAD
CC       pathway. Interacts with UBIAD1. {ECO:0000250|UniProtKB:P04035}.
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane
CC       {ECO:0000250|UniProtKB:P04035}; Multi-pass membrane protein
CC       {ECO:0000250|UniProtKB:P00347}. Peroxisome membrane
CC       {ECO:0000250|UniProtKB:P04035}; Multi-pass membrane protein
CC       {ECO:0000250|UniProtKB:P00347}.
CC   -!- TISSUE SPECIFICITY: High expression found in liver, heart, kidney,
CC       bladder and subcutaneous fat. Lower levels in lung, uterus and large
CC       intestine. Lowest levels in cerebrum, spleen, spinal cord, stomach,
CC       ovary, longissimus muscle, and small intestine.
CC       {ECO:0000269|PubMed:22240315}.
CC   -!- PTM: Undergoes sterol-mediated ubiquitination and ER-associated
CC       degradation (ERAD). Accumulation of sterols in the endoplasmic
CC       reticulum (ER) membrane, triggers binding of the reductase to the ER
CC       membrane protein INSIG1 or INSIG2. The INSIG1 binding leads to the
CC       recruitment of the ubiquitin ligase, AMFR/gp78, RNF139 or RNF145,
CC       initiating ubiquitination of the reductase. The ubiquitinated reductase
CC       is then extracted from the ER membrane and delivered to cytosolic 26S
CC       proteosomes by a mechanism probably mediated by the ATPase Valosin-
CC       containing protein VCP/p97. The INSIG2-binding leads to the recruitment
CC       of the ubiquitin ligase RNF139, initiating ubiquitination of the
CC       reductase. Lys-248 is the main site of ubiquitination. Ubiquitination
CC       is enhanced by the presence of a geranylgeranylated protein.
CC       {ECO:0000250|UniProtKB:P04035}.
CC   -!- PTM: N-glycosylated. Deglycosylated by NGLY1 on release from the
CC       endoplasmic reticulum (ER) in a sterol-mediated manner.
CC       {ECO:0000250|UniProtKB:P04035}.
CC   -!- PTM: Phosphorylated. Phosphorylation at Ser-869 reduces the catalytic
CC       activity. {ECO:0000250|UniProtKB:P00347}.
CC   -!- SIMILARITY: Belongs to the HMG-CoA reductase family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; DQ531631; ABF83891.1; -; Genomic_DNA.
DR   EMBL; DQ432054; ABD96089.1; -; mRNA.
DR   RefSeq; NP_001116460.1; NM_001122988.1.
DR   AlphaFoldDB; Q1W675; -.
DR   SMR; Q1W675; -.
DR   STRING; 9823.ENSSSCP00000014973; -.
DR   BindingDB; Q1W675; -.
DR   ChEMBL; CHEMBL3593154; -.
DR   DrugCentral; Q1W675; -.
DR   iPTMnet; Q1W675; -.
DR   PaxDb; Q1W675; -.
DR   PRIDE; Q1W675; -.
DR   GeneID; 100144446; -.
DR   KEGG; ssc:100144446; -.
DR   CTD; 3156; -.
DR   eggNOG; KOG2480; Eukaryota.
DR   InParanoid; Q1W675; -.
DR   OrthoDB; 907394at2759; -.
DR   BRENDA; 1.1.1.34; 6170.
DR   UniPathway; UPA00058; UER00103.
DR   Proteomes; UP000008227; Unplaced.
DR   Proteomes; UP000314985; Unplaced.
DR   GO; GO:0005783; C:endoplasmic reticulum; ISS:UniProtKB.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; IBA:GO_Central.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005778; C:peroxisomal membrane; ISS:UniProtKB.
DR   GO; GO:0004420; F:hydroxymethylglutaryl-CoA reductase (NADPH) activity; IBA:GO_Central.
DR   GO; GO:0050661; F:NADP binding; IEA:InterPro.
DR   GO; GO:0006695; P:cholesterol biosynthetic process; IEA:UniProtKB-KW.
DR   GO; GO:0015936; P:coenzyme A metabolic process; IEA:InterPro.
DR   GO; GO:0008299; P:isoprenoid biosynthetic process; IBA:GO_Central.
DR   GO; GO:0016126; P:sterol biosynthetic process; IBA:GO_Central.
DR   CDD; cd00643; HMG-CoA_reductase_classI; 1.
DR   Gene3D; 1.10.3270.10; -; 1.
DR   Gene3D; 3.30.70.420; -; 1.
DR   Gene3D; 3.90.770.10; -; 1.
DR   InterPro; IPR002202; HMG_CoA_Rdtase.
DR   InterPro; IPR023074; HMG_CoA_Rdtase_cat_sf.
DR   InterPro; IPR023076; HMG_CoA_Rdtase_CS.
DR   InterPro; IPR004554; HMG_CoA_Rdtase_eu_arc.
DR   InterPro; IPR004816; HMG_CoA_Rdtase_metazoan.
DR   InterPro; IPR023282; HMG_CoA_Rdtase_N.
DR   InterPro; IPR009023; HMG_CoA_Rdtase_NAD(P)-bd_sf.
DR   InterPro; IPR009029; HMG_CoA_Rdtase_sub-bd_dom_sf.
DR   InterPro; IPR000731; SSD.
DR   PANTHER; PTHR10572; PTHR10572; 1.
DR   Pfam; PF00368; HMG-CoA_red; 1.
DR   Pfam; PF12349; Sterol-sensing; 1.
DR   PRINTS; PR00071; HMGCOARDTASE.
DR   SUPFAM; SSF55035; SSF55035; 1.
DR   SUPFAM; SSF56542; SSF56542; 1.
DR   TIGRFAMs; TIGR00920; 2A060605; 1.
DR   TIGRFAMs; TIGR00533; HMG_CoA_R_NADP; 1.
DR   PROSITE; PS00066; HMG_COA_REDUCTASE_1; 1.
DR   PROSITE; PS00318; HMG_COA_REDUCTASE_2; 1.
DR   PROSITE; PS01192; HMG_COA_REDUCTASE_3; 1.
DR   PROSITE; PS50065; HMG_COA_REDUCTASE_4; 1.
DR   PROSITE; PS50156; SSD; 1.
PE   2: Evidence at transcript level;
KW   Cholesterol biosynthesis; Cholesterol metabolism; Endoplasmic reticulum;
KW   Glycoprotein; Isopeptide bond; Lipid biosynthesis; Lipid metabolism;
KW   Membrane; NADP; Oxidoreductase; Peroxisome; Phosphoprotein;
KW   Reference proteome; Steroid biosynthesis; Steroid metabolism;
KW   Sterol biosynthesis; Sterol metabolism; Transmembrane; Transmembrane helix;
KW   Ubl conjugation.
FT   CHAIN           1..885
FT                   /note="3-hydroxy-3-methylglutaryl-coenzyme A reductase"
FT                   /id="PRO_0000258020"
FT   TOPO_DOM        1..9
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250|UniProtKB:P00347"
FT   TRANSMEM        10..39
FT                   /note="Helical"
FT                   /evidence="ECO:0000250|UniProtKB:P00347"
FT   TOPO_DOM        40..56
FT                   /note="Lumenal"
FT                   /evidence="ECO:0000250|UniProtKB:P00347"
FT   TRANSMEM        57..78
FT                   /note="Helical"
FT                   /evidence="ECO:0000250|UniProtKB:P00347"
FT   TOPO_DOM        79..89
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250|UniProtKB:P00347"
FT   TRANSMEM        90..114
FT                   /note="Helical"
FT                   /evidence="ECO:0000250|UniProtKB:P00347"
FT   TOPO_DOM        115..123
FT                   /note="Lumenal"
FT                   /evidence="ECO:0000250|UniProtKB:P00347"
FT   TRANSMEM        124..149
FT                   /note="Helical"
FT                   /evidence="ECO:0000250|UniProtKB:P00347"
FT   TOPO_DOM        150..159
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250|UniProtKB:P00347"
FT   TRANSMEM        160..187
FT                   /note="Helical"
FT                   /evidence="ECO:0000250|UniProtKB:P00347"
FT   TOPO_DOM        188..191
FT                   /note="Lumenal"
FT                   /evidence="ECO:0000250|UniProtKB:P00347"
FT   TRANSMEM        192..220
FT                   /note="Helical"
FT                   /evidence="ECO:0000250|UniProtKB:P00347"
FT   TOPO_DOM        221..248
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250|UniProtKB:P00347"
FT   TRANSMEM        249..275
FT                   /note="Helical"
FT                   /evidence="ECO:0000250|UniProtKB:P00347"
FT   TOPO_DOM        276..314
FT                   /note="Lumenal"
FT                   /evidence="ECO:0000250|UniProtKB:P00347"
FT   TRANSMEM        315..339
FT                   /note="Helical"
FT                   /evidence="ECO:0000250|UniProtKB:P00347"
FT   TOPO_DOM        340..885
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250|UniProtKB:P00347"
FT   DOMAIN          61..218
FT                   /note="SSD"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00199"
FT   MOTIF           75..78
FT                   /note="INSIG-binding motif"
FT                   /evidence="ECO:0000250|UniProtKB:P04035"
FT   ACT_SITE        558
FT                   /note="Charge relay system"
FT                   /evidence="ECO:0000250|UniProtKB:P04035"
FT   ACT_SITE        688
FT                   /note="Charge relay system"
FT                   /evidence="ECO:0000250|UniProtKB:P04035"
FT   ACT_SITE        764
FT                   /note="Charge relay system"
FT                   /evidence="ECO:0000250|UniProtKB:P04035"
FT   ACT_SITE        863
FT                   /note="Proton donor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU10003"
FT   MOD_RES         869
FT                   /note="Phosphoserine; by AMPK"
FT                   /evidence="ECO:0000250|UniProtKB:P51639"
FT   CARBOHYD        281
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        296
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CROSSLNK        89
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin)"
FT                   /evidence="ECO:0000250|UniProtKB:P00347"
FT   CROSSLNK        248
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin)"
FT                   /evidence="ECO:0000250|UniProtKB:P00347"
SQ   SEQUENCE   885 AA;  97151 MW;  046E93BF1155FAD2 CRC64;
     MLSRLFRMHG LFVASHPWEV IVGTVTLTIC MMSMNMFTGN DKICGWNYEC PKFEEDVLSS
     DIIILTITRC IAILYIYFQF QNLRQLGSKY ILGIAGLFTI FSSFVFSTVV IHFLDKELTG
     LNEALPFFLL LIDLSRASAL AKFALSSNSQ DEVRENIARG MAILGPTFTL DALVECLVIG
     VGTMSGVRQL EIMCCFGCMS VLATYFVFMT FFPACVSLVL ELSRESREGR PIWQLSHFAR
     VLEGEENKPN PVTQRVKIIM SLGLVLVHAH SRWIADPSPQ NSTADNSKVS LGLDENVSKR
     IEPSVSLWQF YLSKMISMDI EQVITLTLAL LLAVKYIFFE QAETESTLSL KNPITSPVVT
     QKKVTDDCCR REPTLVRNDQ KFHTVEEEAR INRERKVEVI KPLVAETDTS SRPTFVVGNS
     TLDSSLELEM QEPEIQIPSE PRPNEECLQI LGNAEKGAKF LSDAEIIQLV NAKHIPAYKL
     ETLMETHERG VSIRRQLLSK KLPEPSSLQY LPYRDYNYSL VMGACCENVI GYMPIPVGVA
     GPLCLDGKEF QVPMATTEGC LVASTNRGCR AIGLGGGASS RILADGMTPV VRFPRACDSA
     EVKAWLETPE GFAVIKEAFD STSRFARLQK LQMSVAGRNL YIRFQSRSGD AMGMNMISKG
     TEKALSKLHE YFPEMQILAV SGNYCTDKKP AAVNWIEGRG KSVVCEAVIP AKVVREVLKT
     TTEAMVEVNI NKNLVGSAMA GSIGGYNAHA ANIVTAIYIA CGQDAAQNVG SSNCITLMEA
     SGPTNEDLYI SCTMPSIEIG TVGGGTSLLP QQACLQMLGV QGACKDNPGE NARQLARIVC
     GTVMAGELSL MAALAAGHLV RSHMIHNRSK INLQDLQGTC TKKAA
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024